Project Grant R61NS140724
Award Date
12/24/24
Completion Date
11/30/26
Dollars Obligated
$374K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
The $427,625 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program will support research at The Washington University in St. Louis to develop a novel cellular model for studying amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The research will employ direct conversion of fibroblasts into induced motor neurons...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,001,864 to Harvard University to investigate the subcellular mechanisms underlying the selective vulnerability of specific neuron subtypes in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will quantitatively study the localization of RNA, proteins, and translational regulation in the synapses and soma of vulnerable corticospinal neurons (CSN) and...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $460,625 to the University of Massachusetts Medical School to develop mutant-specific antisense oligonucleotides (ASOs) as potential therapeutics for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The research aims to design and evaluate...
This Project Grant award of $2,219,913 from the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate environmental risk factors linked to TDP-43 proteinopathies, a hallmark of neurodegenerative disorders like frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The 5-year project, led by the University of North Carolina at Chapel Hill, will evaluate a subset of environmental toxicants identified through...
This $1,157,896 Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), will fund research at Brown University focused on elucidating the mechanistic basis of transketolase-mediated suppression of neurodegeneration in amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD). The grantee will study multiple models of ALS/FTD using Drosophila genetics and analyze molecular readouts such as redox state, autophagy,...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $340,258 to Emory University to assess the contribution of cortical hyperactivity to amyotrophic lateral sclerosis (ALS) phenotypes in a human-derived motor system model. The key products or services to be delivered through this 3-year project include: Interrogating changes...
This $558,182 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund research to identify mechanisms of neurofilament regulation and turnover in amyotrophic lateral sclerosis (ALS). The research team at The Washington University in St. Louis will use advanced proteomic and protein kinetic analysis techniques to examine neurofilament isoforms...
This $538,380 Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) will support research at the Vlaams Instituut Voor Biotechnologie (VIB) in Gent, Belgium to study frontotemporal lobar degeneration (FTLD), a neurodegenerative disorder. The key objectives are to: 1) Develop a humanized FTLD-TDP mouse model by transplanting patient-derived GRN-deficient microglia into human TMEM106B overexpressing mice to study FTLD pathology; 2) Identify...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $654,423 to Emory University for a study on the mechanisms of chimeric dipeptide repeat (DPR) proteins and their role in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) associated with C9ORF72 gene expansions. The primary objectives are to: 1) identify the complexity, extent, and mechanism of chimeric DPR (cDPR) pathology in C9ALS/FTD, 2)...
This $1,138,538 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports the expansion of research insights into frontotemporal lobar degeneration (FTLD) disease mechanisms. The primary awardee, Mayo Clinic Jacksonville (A Nonprofit Corporation), is conducting a comprehensive investigation of key molecular drivers of FTLD,...